The role of caspase activity in the viral response of pegylated interferon alfa-2B plus ribavirin therapy

被引：0
|
作者：
Oze, Tsugiko
Hiramatsu, Naoki
Kanto, Tatsuya
Kurashige, Nao
Yakushijin, Takayuki
Uyama, Hirokazu
Igura, Takumi
Oshita, Masahide
Katayama, Kazuhiro
Yoshihara, Harumasa
Imai, Yasuharu
Kato, Michio
Takehara, Tetsuo
Kasahara, Akinori
Tamura, Shinji
Hayashi, Norio
机构：
[1] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan
[2] Osaka Police Hosp, Osaka, Japan
[3] Osaka Kouseinenkin Hosp, Osaka, Japan
[4] Osaka Rousai Hosp, Sakai, Osaka, Japan
[5] Ikeda City Hosp, Ikeda, Osaka, Japan
[6] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
333
引用
收藏
页码：313A / 314A
页数：2
相关论文
共 50 条
  • [31] Consensus interferon and ribavirin in patients with chronic hepatitis c who were nonresponders to pegylated interferon alfa-2b and ribavirin
    Leevy, Carroll B.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1961 - 1966
  • [32] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [33] Comparison of pegylated interferon alfa-2a and alfa-2b in combination with ribavirin in obese patients with chronic hepatitis
    Moore, CH
    Angtuaco, TL
    Lindsey, JL
    Nelson, SD
    Malik, AH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S109 - S109
  • [34] Pegylated interferon alfa-2b and ribavirin in HIV/HCV-coinfected patients.
    Myers, RP
    Benhamou, Y
    Bochet, M
    Mehri, D
    Di Martino, V
    Valantin, MA
    Katlama, C
    Bricaire, F
    Poynard, T
    HEPATOLOGY, 2002, 36 (04) : 575A - 575A
  • [35] Incidence of Neutropenia and Infections During Combination Treatment of Chronic Hepatitis C with Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin
    M. G. Antonini
    S. Babudieri
    I. Maida
    C. Baiguera
    B. Zanini
    L. Fenu
    G. Dettori
    D. Manno
    M. S. Mura
    G. Carosi
    M. Puoti
    Infection, 2008, 36 : 250 - 255
  • [36] Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4.
    Esmat, G
    Abouzied, AM
    Abdel-Aziz, F
    Mohamed, MK
    Abdel-Hamid, M
    El Raziky, MS
    Ismail, SA
    Zalata, KR
    Mikhail, NN
    Fix, A
    Strickland, T
    Sjogren, MH
    HEPATOLOGY, 2002, 36 (04) : 364A - 364A
  • [37] Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin
    Antonini, M. G.
    Babudieri, S.
    Maida, I.
    Baiguera, C.
    Zanini, B.
    Fenu, L.
    Dettori, G.
    Manno, D.
    Mura, M. S.
    Carosi, G.
    Puoti, M.
    INFECTION, 2008, 36 (03) : 250 - 255
  • [38] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers.
    Jacobson, I
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    HEPATOLOGY, 2002, 36 (04) : 358A - 358A
  • [39] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers.
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    HEPATOLOGY, 2001, 34 (04) : 338A - 338A
  • [40] Treatment of Recurrent Hepatitis C (Genotype 1) with Pegylated Interferon Alfa-2b and Ribavirin Combination and Maintenance Therapy
    Testino, Gianni
    Sumberaz, Alessandro
    Ansaldi, Filippo
    Borro, Paolo
    Leone, Silvia
    Ancarani, A. Ornella
    Gentile, Raffaella
    Icardi, Giancarlo
    HEPATO-GASTROENTEROLOGY, 2011, 58 (106) : 536 - 538
12345